article thumbnail

Leveraging Genetic Testing for Enrolling Rare Disease Trials

Worldwide Clinical Trials

Written By: Derek Ansel, MS, CCRA, Executive Director, Therapeutic Strategy Lead, Rare Disease Given that 80% of rare diseases have a genetic etiology, genetic implications should be addressed at the onset of a clinical program to support trial enrollment. One diagnostic example that I discussed in my presentation is autism.

Genetics 189
article thumbnail

Nature publishes new research on genetic causes of colorectal cancer

Pharma Times

In the UK study, researchers analysed 2,023 bowel cancers from the 100,000 Genomes Project

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

‘100 Million Cell Challenge’ to boost single cell genomics research

Drug Discovery World

Scale Biosciences (Scale Bio) has launched the ‘100 Million Cell Challenge’, which hopes to push the boundaries of single-cell genomics research, in collaboration with Ultima Genomics and NVIDIA. Researchers interested in participating can submit their project proposals from 8 August to 15 October 2024.

Genome 59
article thumbnail

Genetic causes of colorectal cancer revealed in new study

Drug Discovery World

A new study has provided the most comprehensive analysis to date of the genetic makeup of colorectal cancer (CRC), providing unique understanding of its response to treatment. They’ve also uncovered new CRC cancer sub-groups (categories of cancer with specific genetic characteristics that affect how cancer behaves and responds to treatment).

article thumbnail

Clonal Hematopoiesis and Cancer Genetics: How Are They Linked, How Is Research Evolving?

XTalks

One of the more intriguing developments in cancer research in recent years is the growing understanding of clonal hematopoiesis, a phenomenon where blood cells expand from a single clone due to genetic mutations. Clonal hematopoiesis increases in prevalence with age and can precede hematologic malignancies.

Genetics 114
article thumbnail

Researchers identify potential new genetic target for cancer drugs

Drug Discovery World

UK researchers have mapped the exact variants in a gene that dramatically increase a person’s risk of developing cancer, paving the way for targeted treatment across diverse populations. The research team tested all 18,108 possible DNA changes in the BAP1 gene using ‘saturation genome editing’.

article thumbnail

Emmes and MedGenome Launch Genomics Strategic Partnership Focused on Advancing Rare Disease Research

Pharma Mirror

Rockville, Emmes, a global, full-service Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced a partnership with MedGenome aimed at accelerating breakthrough treatments, powered by human genomics, for rare disease patients.

Genome 130